Are BASF and Dow in Crisis? Understanding the New Reality of the Global Chemical Industry

Introduction

For much of the past two decades, the world’s largest chemical companies operated on a fairly stable strategic assumption: demand would recover, global trade would remain broadly open, large integrated sites would continue to deliver scale advantages, and cyclical downturns would eventually correct themselves. That assumption is now under serious strain. The current pressure on BASF and Dow is not only about one weak year, one bad pricing cycle, or one temporary demand shock. It reflects something deeper: the global chemical industry is being forced into a structural reset.

In that context, the question “Are BASF and Dow in crisis?” deserves a nuanced answer. Yes, both companies are clearly under pressure. BASF reported 2025 sales of €59.657 billion, EBITDA before special items of €6.554 billion, and EBIT of €1.634 billion, while highlighting falling prices across most segments and a difficult environment, especially in Europe. Dow’s 2025 picture looked even more severe: $40.0 billion in net sales, a GAAP net loss of $2.4 billion, operating EBIT of just $0.4 billion, and operating cash flow of $1.1 billion. Those are not normal comfort-zone numbers for two of the industry’s most established names.

At the same time, calling this simply a collapse would be too crude. BASF and Dow are not disappearing. They are restructuring, simplifying, cutting costs, reassessing assets, and trying to reposition themselves for a harsher competitive era. The real story is not whether chemicals still matter. They do. The real story is whether the old model of winning in chemicals still works.

The Global Chemical Industry Is Not in a Normal Downturn

What makes the present moment so important is that the problems are no longer merely cyclical. Europe is dealing with structurally high energy costs, global demand is softer than many producers expected, import pressure is intensifying, and China’s role in global chemicals has changed from major participant to dominant force in several value chains. According to Cefic, Europe’s share of the global chemical market has fallen to 13%, while China now accounts for 46% of global sales. Cefic also says European gas prices remain three times higher than in the United States, and capacity utilisation is still 9.5% below pre-crisis levels. Those are not the signs of a brief pause before a strong rebound. They are the signs of a region losing cost competitiveness.

That pressure becomes even clearer when one looks at Germany, one of the historic centres of industrial chemistry. The VCI reported that capacity utilisation at German chemical plants averaged only 72.5% in 2025, which it describes as below the profitability threshold. In the fourth quarter of 2025, total sales in the German chemical and pharmaceutical industry were €51.8 billion, 2.8% below the previous year, while weak industrial demand, high import pressure, and intense price competition continued to weigh on the sector. If the industrial heartland of European chemicals is operating below profitable utilisation, that is not just cyclical softness; it is a warning about structural economics.

China’s overcapacity makes the problem even more serious. The industry is facing a permanent shift in the balance of global manufacturing power, not a temporary imbalance. In some chains, the excess is extraordinary: epichlorohydrin at 93% excess capacity versus rest-of-world demand, siloxanes at 69%, epoxy at 35%, and phenolics at 23%. When overcapacity reaches that scale, pricing pressure can last far longer than traditional Western industry cycles would suggest. That is why the present moment feels more severe than a normal downturn.

Why BASF Looks Pressured, Not Broken?

BASF remains one of the most strategically important companies in the global chemical sector, but its 2025 results show clearly that its traditional strengths are under strain. Sales declined to €59.657 billion from €61.444 billion, and EBITDA before special items fell by €686 million to €6.554 billion. BASF attributed the pressure to negative currency effects, lower prices in almost all segments, and weaker contribution margins in key businesses. Even more tellingly, the company said prices fell in nearly all segments, with only Surface Technologies and Nutrition & Care showing price increases.

The deeper signal lies in BASF’s own language about Europe. In its 2025 report, BASF says the chemical industry is facing major challenges worldwide, particularly in Europe. It also says Europe and Germany need rapid and far-reaching political reforms if industrial competitiveness is to be restored and if green transformation goals are to remain economically viable. BASF is not speaking here as a marginal producer. It is speaking as one of Europe’s flagship industrial companies. When such a company openly raises concerns about the competitiveness of its home base, that should be interpreted as a structural warning, not ordinary corporate caution.

What BASF is doing in response also matters. The company says it is making progress with its “Winning Ways” strategy, streamlining core businesses, simplifying the organisation, and targeting more than €2.3 billion in savings by the end of 2026 versus the 2022 base year. That does not sound like a company waiting patiently for the cycle to repair itself. It sounds like a company adapting to a new industrial logic in which large European assets can no longer rely on the old combination of scale, integration, and market recovery. BASF is not broken, but it is clearly being forced to reinvent parts of its operating model.

Why Dow Looks More Visibly in Crisis

Dow’s 2025 results make the industry’s stress even harder to ignore. Full-year net sales fell to $40.0 billion from $43.0 billion in 2024. The company moved from a GAAP net income of $1.2 billion in 2024 to a GAAP net loss of $2.4 billion in 2025. Operating EBIT dropped to $0.4 billion from $2.6 billion, and operating cash flow fell to $1.1 billion from $2.9 billion. Dow itself pointed to price declines, lower operating rates, margin compression, and softer demand in building and construction markets. This is not a mild earnings dip. It is a sharp compression in profitability and cash generation.

Dow’s actions confirm that management sees the issue as fundamental, not merely temporary. The company said it had delivered well over half of more than $6.5 billion in near-term cash and cost support actions, including accelerated delivery of more than $400 million in savings from a $1 billion cost programme. It also highlighted the idling of a cracker in the EMEAI region and framed its “Transform to Outperform” initiative as a comprehensive simplification of the operating model aimed at delivering at least $2 billion in additional near-term earnings. Companies do not use that kind of language when they believe the problem will resolve itself quickly.

In Dow’s case, the crisis is especially visible because it sits so directly at the intersection of commodity exposure, operating-rate pressure, and investor expectations around cash flow discipline. The company still has advantaged positions, valuable infrastructure, and technical depth, but its results show how brutally the market can punish cyclical and petrochemical-heavy exposure when supply exceeds demand for too long. Dow’s challenge is not whether it can survive. Its challenge is whether it can restore a level of earnings quality that fits its scale and shareholder expectations in a structurally tougher market.

Demand Has Not Disappeared — but Value Capture Has Become Harder

One of the biggest mistakes in analysing the current chemical industry outlook is to assume that pressure on BASF and Dow means the underlying market has stopped growing. In reality, chemicals remain fundamental to manufacturing, mobility, infrastructure, agriculture, packaging, construction, and advanced materials. The demand base is still there. What has changed is the economics of capturing that demand profitably.

According to TechSci Research, the global basic chemicals market stood at USD 696.88 billion in 2024 and is projected to reach USD 926.40 billion by 2030. In specialty chemicals, the market was valued at USD 933.89 billion in 2024 and is projected to rise to USD 1,315.41 billion by 2030. Meanwhile, the global petrochemicals market is estimated at USD 664.39 billion in 2025 and projected to reach USD 1,079.74 billion by 2031. Those are not the numbers of an irrelevant industry. They show that chemical demand remains large and financially important across the global economy.

The same pattern appears in more specific product chains. TechSci Research places the global propylene market at USD 70.60 billion in 2024, with a projection of USD 101.58 billion by 2030. It also places the global methylene diphenyl diisocyanate market at USD 28.92 billion in 2025, rising to USD 42.75 billion by 2031. Again, the strategic message is not that demand is vanishing. The message is that even markets with substantial size and growth potential do not automatically guarantee healthy margins for incumbent producers. If capacity expands too quickly, if cost positions diverge too sharply by region, or if end-market growth is captured by lower-cost producers, then large addressable markets can coexist with weak returns.

That distinction is vital. BASF and Dow are not suffering because chemicals no longer matter. They are suffering because the path from volume to value has become less reliable. In other words, the world still needs chemicals, but it is becoming less generous to the companies that produce them unless they have the right regional footprint, portfolio mix, cost discipline, and pricing power. That is the essence of the new reality.

What the New Competitive Model Looks Like

The companies most likely to outperform in the next era of chemicals will not necessarily be the ones with the biggest historic asset base. They will be the ones that move fastest from commodity dependence to differentiated value creation. Western chemical producers need to shift from scale to specialisation, from global to regional operating models, and from passive hope in market recovery to active capital reallocation. That framework is increasingly visible in what BASF and Dow are already trying to do.

For BASF, that means protecting the value of integration where it still works while becoming more selective about where Europe can realistically remain competitive. For Dow, it means defending cash flow, simplifying the portfolio, and ensuring that scale does not become a trap in under-earning segments. For the wider industry, it means a sharper focus on specialty solutions, local-for-local manufacturing where appropriate, digital and operating efficiency, and more disciplined investment decisions. The era in which sheer size was enough to win is fading. The new model rewards resilience, positioning, and the courage to exit businesses that no longer create acceptable returns.

Conclusion

So, are BASF and Dow in crisis? Yes but it is important to define the crisis correctly. This is not mainly a crisis of relevance, and it is not yet a crisis of corporate survival. It is a crisis of industrial adaptation. BASF is confronting a European cost base that has become harder to defend and a competitive environment that is undermining pricing across large parts of its portfolio. Dow is confronting severe pressure on earnings, cash flow, and operating rates at a time when investors want discipline, not excuses. Both companies are being forced to redesign how they compete.

The broader lesson for the global chemical industry is even more significant. The industry is not dying, but the old playbook is. Europe’s energy disadvantage, China’s overcapacity, weak utilisation, import pressure, and investor demands for stronger returns have created a tougher environment than the one chemical majors grew used to in earlier decades. In that environment, market size alone is not enough, historical scale is not enough, and cyclical patience is not enough. Strategy now matters more. Portfolio quality matters more. Regional economics matter more. Execution matters more.